Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

9480	Companies
185543	Keywords
117939	Articles
99384	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 07/03/2025 at 07:00, 5 months 2 days ago

Biophytis Propulse l’Innovation dans l’Obésité, la Santé Musculaire et la Longévité à la BIO International 2025
BiophyHs SA présente ses avancées dans l'obésité, la sarcopénie et la longévité à la BIO Interna(onal 2025, soulignant ses thérapies innovantes et partenariats stratégiques pour le développement mondial

Longévité Sarcopénie Obésité BiophyHs SA BIO InternaHonal 2025
PRESS RELEASE

published on 07/03/2025 at 06:59, 5 months 2 days ago

Biophytis Propulse l’Innovation dans l’Obésité, la Santé Musculaire et la Longévité à la BIO International 2025
BiophyHs annonce son succès à la BIO International Convention 2025, présentant des avancées en obésité, sarcopénie et longévité, avec des partenariats stratégiques post-conférence

Longévité Sarcopénie Obésité BIO International Convention 2025 BiophyHs
BRIEF

published on 06/30/2025 at 22:35, 5 months 4 days ago

Biophytis reporte la publication de ses comptes annuels

Biophytis Biotechnologie Comptes Annuels Recherche Clinique Publication Retardée
BRIEF

published on 06/30/2025 at 22:35, 5 months 4 days ago

Biophytis Delays Publication of 2024 Annual Financial Statements

Biophytis Biotechnology Drug Development Annual Accounts Financial Delay
REGULATED PRESS RELEASE

published on 06/30/2025 at 22:30, 5 months 4 days ago

Information sur les comptes annuels
Biophytis SA informe qu'elle n'est pas en mesure de publier ses comptes annuels 2024 à la date prévue mais les publiera au plus tard le 07 juillet 2025

Biophytis Développement Biotechnologie Comptes Annuels Maladies Liées À L'âge
REGULATED PRESS RELEASE

published on 06/30/2025 at 22:30, 5 months 4 days ago

Information on the Annual Financial Statements
Biophytis delays publishing of 2024 annual accounts, aiming for release by July 7. The company focuses on treatments for age-related diseases

Financial Statements Biophytis Age-related Diseases 2024 Annual Accounts Clinical-stage Biotechnology Company
PRESS RELEASE

published on 06/30/2025 at 22:29, 5 months 4 days ago

Information sur les comptes annuels
Biophytis SA informe qu'elle reporte la publication de ses comptes annuels 2024 mais s'engage pour une publication rapide. Analyse des risques liés aux déclarations prospectives incluses

Comptes Annuels Déclarations Prospectives Publication Biophytis SA Risques
PRESS RELEASE

published on 06/30/2025 at 22:29, 5 months 4 days ago

Information on the Annual Financial Statements
Biophytis SA delays publication of 2024 annual accounts, aiming to release by July 7. The clinical-stage biotech company focuses on age-related disease treatments

Biotechnology Company Clinical-stage Biophytis SA Age-related Diseases 2024 Annual Accounts
BRIEF

published on 06/19/2025 at 23:05, 5 months 15 days ago

Biophytis suspend temporairement la cotation de son action

Biophytis Euronext Growth Rapport Financier Suspension Cotation Certification Comptes
BRIEF

published on 06/19/2025 at 23:05, 5 months 15 days ago

Biophytis Temporarily Suspends Share Trading

Biophytis Regulatory Compliance Financial Report Euronext Growth Share Suspension

Accesswire

Published on 12/05/2025 at 20:25, 44 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 54 minutes ago

When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 1 hour 19 minutes ago

Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 1 hour 49 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 2 hours 24 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 2 hours 11 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 2 hours 43 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 2 hours 54 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 3 hours 18 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 3 hours 23 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 3 hours 51 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 3 hours 51 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 58 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 hours 58 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 7 hours 11 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE